| Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis G Kim, SH Kang, MY Kim, SK Baik PloS one 12 (10), e0186990, 2017 | 413 | 2017 |
| Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy JH Kim, YD Kim, M Lee, BG Jun, TS Kim, KT Suk, SH Kang, MY Kim, ... Journal of hepatology 69 (5), 1066-1073, 2018 | 237 | 2018 |
| KASL clinical practice guidelines: management of nonalcoholic fatty liver disease SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim, TH Lee, BK Jang, SG Kim, ... Clinical and molecular hepatology 27 (3), 363, 2021 | 229 | 2021 |
| Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score SH Kang, WK Jeong, SK Baik, SH Cha, MY Kim Journal of cachexia, sarcopenia and muscle 9 (5), 860-870, 2018 | 147 | 2018 |
| Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy SH Kang, YB Lee, JH Lee, JY Nam, Y Chang, H Cho, JJ Yoo, YY Cho, ... Alimentary Pharmacology & Therapeutics 46 (9), 845-855, 2017 | 144 | 2017 |
| Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension KY Shim, YW Eom, MY Kim, SH Kang, SK Baik The Korean Journal of Internal Medicine 33 (3), 453, 2018 | 99 | 2018 |
| From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple? SH Kang, Y Cho, SW Jeong, SU Kim, JW Lee, ... Clinical and molecular hepatology 27 (2), 257, 2021 | 87 | 2021 |
| Mesenchymal stem cells for the treatment of liver disease: present and perspectives SH Kang, MY Kim, YW Eom, SK Baik Gut and liver 14 (3), 306, 2019 | 72 | 2019 |
| Proton pump inhibitor therapy is associated with reduction of early bleeding risk after prophylactic endoscopic variceal band ligation: a retrospective cohort study SH Kang, HJ Yim, SY Kim, SJ Suh, JJ Hyun, SW Jung, YK Jung, JS Koo, ... Medicine 95 (8), e2903, 2016 | 60 | 2016 |
| BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A YK Jung, CH Jung, YS Seo, JH Kim, TH Kim, YJ Yoo, SH Kang, SY Yim, ... Journal of gastroenterology and hepatology 31 (2), 467-474, 2016 | 56 | 2016 |
| Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study SH Kang, DH Cho, J Choi, SK Baik, JG Gwon, MY Kim PLoS One 16 (10), e0258229, 2021 | 44 | 2021 |
| Preparation and patient evaluation for safe gastrointestinal endoscopy SH Kang, JJ Hyun Clinical Endoscopy 46 (3), 212-218, 2013 | 43 | 2013 |
| Comparison of sorafenib versus hepatic arterial infusion chemotherapy-based treatment for advanced hepatocellular carcinoma with portal vein tumor thrombosis YE Ahn, SJ Suh, HJ Yim, YS Seo, EL Yoon, TH Kim, YS Lee, SY Yim, ... Gut and Liver 15 (2), 284, 2020 | 40 | 2020 |
| An explorative analysis for the role of serum miR-10b-3p levels in predicting response to sorafenib in patients with advanced hepatocellular carcinoma EL Yoon, JE Yeon, E Ko, HJ Lee, JH Je, YJ Yoo, SH Kang, SJ Suh, ... Journal of Korean Medical Science 32 (2), 212-220, 2017 | 38 | 2017 |
| Prediction of the varices needing treatment with non‐invasive tests in patients with compensated advanced chronic liver disease HA Lee, SU Kim, YS Seo, YS Lee, SH Kang, YK Jung, MY Kim, JH Kim, ... Liver International 39 (6), 1071-1079, 2019 | 37 | 2019 |
| Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: a multicenter study BG Jun, YD Kim, SG Kim, YS Kim, SW Jeong, JY Jang, SH Lee, HS Kim, ... PLoS One 13 (7), e0201316, 2018 | 36 | 2018 |
| Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease JH Ahn, JS Yu, KS Park, SH Kang, JH Huh, JS Chang, JH Lee, MY Kim, ... Magnetic Resonance Imaging 80, 1-8, 2021 | 29 | 2021 |
| Accuracy of noninvasive scoring systems in assessing liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis S Han, M Choi, B Lee, HW Lee, SH Kang, Y Cho, SB Ahn, DW Jun, J Lee, ... Gut and Liver 16 (6), 952, 2022 | 28 | 2022 |
| Treatment of severe alcoholic hepatitis with corticosteroid, pentoxifylline, or dual therapy: a systematic review and meta-analysis YS Lee, HJ Kim, JH Kim, YJ Yoo, TS Kim, SH Kang, SJ Suh, MK Joo, ... Journal of Clinical Gastroenterology 51 (4), 364-377, 2017 | 28 | 2017 |
| Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon SH Kang, MY Kim, SK Baik Hepatology International 12, 112-121, 2018 | 27 | 2018 |
